REGISTER
Dr.Jin Li & Dr. Ken Kato at CSCO 2025
Recent data bring fresh attention to Dr.Jin Li & Dr. Ken Kato at CSCO 2025. The summary connects evidence on CSCO, MD, kato with who may benefit, what risks matter most, and how practice could change.

Jin Li, MD, from Shanghai GaoBo Tumor Hospital (Affiliated to China Pharmaceutical University) and Ken Kato, MD, from the National Cancer Center Hospital, Japan, engaged in a collaborative discussion:

Breakthroughs in perioperative immunotherapy for esophageal cancer have been achieved, with multidisciplinary collaboration and international cooperation jointly driving advancements in treatment.

0
0
Loading